Pastan, Ira H. Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Federal Dockets	16
Active	1982–2007
Patent Assignments	102

On PlainSite Chat

No one has posted about Pastan, Ira H. yet.

Share something about Pastan, Ira H.:

Add a document

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

8/29/2024	The United States Of America	Assignee	Application Publication	18710726 20250018040	Anti-mesothelin Polypeptides, Proteins, And Chimeric Antigen Receptors Anti-mesothelin Polypeptides, Proteins, And Chimeric Antigen Receptors

8/29/2024	The United States Of America	Assignee	Application Publication	18710726 20250018040	Anti-mesothelin Polypeptides, Proteins, And Chimeric Antigen Receptors Anti-mesothelin Polypeptides, Proteins, And Chimeric Antigen Receptors

5/21/2024	The Government Of The United States As R...	Assignee	Application Publication	18428597 20240350624

5/21/2024	The Government Of The United States As R...	Assignee	Application Publication	18428597 20240350624	Combination Therapy of Immunotoxin and Checkpoint Inhibitor Combination Therapy of Immunotoxin and Checkpoint Inhibitor

5/21/2024	The Government Of The United States As R...	Assignee	Application Publication	18428597 20240350624	Combination Therapy of Immunotoxin and Checkpoint Inhibitor Combination Therapy of Immunotoxin and Checkpoint Inhibitor

3/7/2023	The United States Of America	Assignee	Application	PCT/US2022/0	Anti-mesothelin Polypeptides, Proteins, And Chimeric Antigen Receptors

7/8/2021	The United States Of America	Assignee	Application Publication	17421334 20220064324	Cross Species Single Domain Antibodies Targeting Mesothelin For Treating... Cross Species Single Domain Antibodies Targeting Mesothelin For Treating...

7/8/2021	The United States Of America	Assignee	Application Publication Patent	17421334 20220064324 12180296	Cross Species Single Domain Antibodies Targeting Mesothelin For Treating... Cross Species Single Domain Antibodies Targeting Mesothelin For Treating... Cross Species Single Domain Antibodies Targeting Mesothelin For Treating...

11/17/2020	The United States Of America	Assignee	Application Publication Patent	15773687 20180318435 10925969	Anti-bcma Polypeptides And Proteins Anti-bcma Polypeptides And Proteins Anti-bcma Polypeptides And Proteins

7/9/2020	The United States Of America	Assignee	Application Publication	16648369 20200223937	Immunotoxins With Albumin Binding Domain Immunotoxins With Albumin Binding Domain

7/9/2020	The United States Of America	Assignee	Application Publication Patent	16648369 20200223937 11795235	Immunotoxins With Albumin Binding Domain Immunotoxins With Albumin Binding Domain Immunotoxins With Albumin Binding Domain

1/14/2020	The United States Of America	Assignee	Application Publication	16613971 20200247901	Anti-mesothelin Polypeptides And Proteins Anti-mesothelin Polypeptides And Proteins

7/18/2018	The Government Of The United States As R...	Assignee	Application Publication	14903659 20160168263	Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules

7/18/2018	The Government Of The United States As R...	Assignee	Application Publication Patent	14903659 20160168263 10053514	Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules Human Bispecific EGFRvIII and CD3 Antibody Engaging Molecules

7/18/2018	The Government Of The United States As R...	Assignee	Application Publication Patent	14903659 20160168263 10053514	Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules Human Bispecific EGFRvIII and CD3 Antibody Engaging Molecules Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules

7/11/2018	The Government Of The United States As R...	Assignee	Application Publication	15773418 20180311346	Combination Therapy Of Immunotoxin And Checkpoint Inhibitor Combination Therapy Of Immunotoxin And Checkpoint Inhibitor

3/1/2017	The Government Of The United States Of A...	Assignee	Application Publication	15424238 20170145097	Human Monoclonal Antibodies Specific For Cd22 Human Monoclonal Antibodies Specific For Cd22

3/1/2017	The Government Of The United States Of A...	Assignee	Application Publication Patent	15424238 20170145097 10494435	Human Monoclonal Antibodies Specific For Cd22 Human Monoclonal Antibodies Specific For Cd22 Human Monoclonal Antibodies Specific For Cd22

10/11/2016	The United States Government As Represen...	Assignee	Application Publication	15290040 20170051064

10/11/2016	The United States Government As Represen...	Assignee	Application Publication Application	15290040 20170051064 10072084	Dual Specific Immunotoxin for Brain Tumor Therapy Dual Specific Immunotoxin for Brain Tumor Therapy

10/11/2016	The United States Government As Represen...	Assignee	Application Publication Patent	15290040 20170051064 10072084	Dual Specific Immunotoxin for Brain Tumor Therapy Dual Specific Immunotoxin for Brain Tumor Therapy Dual Specific Immunotoxin for Brain Tumor Therapy

6/3/2016	The United States Government As Represen...	Assignee	Application Publication	15171018 20160272730	Antibodies for Tumor Gangliosides Antibodies for Tumor Gangliosides

6/3/2016	The United States Government As Represen...	Assignee	Application Publication Application	15171018 20160272730 10052382	Antibodies for Tumor Gangliosides Antibodies for Tumor Gangliosides

5/20/2016	The United States Of America	Assignee	Application Publication	15141006 20160229919	Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof

5/20/2016	The United States Of America	Assignee	Application Publication Patent	15141006 20160229919 9803022	Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof

2/25/2016	The Government Of The United States Of A...	Assignee	Application Publication	15012023 20160145338	Human Monoclonal Antibodies Specific For Cd22 Human Monoclonal Antibodies Specific For Cd22

2/25/2016	The Government Of The United States Of A...	Assignee	Application Publication Patent	15012023 20160145338 9598492	Human Monoclonal Antibodies Specific For Cd22 Human Monoclonal Antibodies Specific For Cd22 Human Monoclonal Antibodies Specific For Cd22

6/26/2015	The United States Of America	Assignee	Application Publication	14437889 20150299317	M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors

6/26/2015	The United States Of America	Assignee	Application Publication Application	14437889 20150299317 10072078	M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors

6/26/2015	The United States Of America	Assignee	Application Publication Patent	14437889 20150299317 10072078	M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors

6/26/2015	The United States Of America	Assignee	Application Publication Patent	14437889 20150299317 10072078	M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors

4/1/2015	The United States Of America	Assignee	Application Publication Patent	14428771 20150274836 9416190	Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activit... Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activit... Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activit...

2/19/2015	The United States Of America	Assignee	Application Publication Patent	14421599 20150252118 9409992	Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof

2/5/2015	The United States Government As Represen...	Assignee	Application Application Publication Publication	14406161 14406161 20150132306 20150132306

2/5/2015	The United States Government As Represen...	Assignee	Application Application Publication Publication Application Application	14406161 14406161 20150132306 20150132306 9676858 9676858	HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES

12/10/2014	The United States Of America	Assignee	Application Publication Patent	14505590 20150099707 9388222	Modified Pseudomonas Exotoxin A Rstp Aggregration Scheme For Ethernet Networks Modified Pseudomonas Exotoxin A

11/13/2014	The United States Government As Represen...	Assignee	Application Publication Patent	14270836 20140322248 9492564	Double Pole-double Throw Proximity Switch Dual Specific Immunotoxin for Brain Tumor Therapy Dual Specific Immunotoxin for Brain Tumor Therapy

11/13/2014	The United States Government As Represen...	Assignee	Application Publication Patent	14270836 20140322248 9492564	Dual Specific Immunotoxin for Brain Tumor Therapy Dual Specific Immunotoxin for Brain Tumor Therapy Dual Specific Immunotoxin for Brain Tumor Therapy

10/10/2014	The United States Of America	Assignee	Application Publication Patent	14496194 20150010590 9394352	Flexible Organic Light Emitting Diode Display And Manufacturing Method T... Immunogenic Pote Peptides And Methods Of Use Immunogenic Pote Peptides And Methods Of Use

10/9/2014	The United States Of America	Assignee	Application Publication Patent	14384282 20150031624 9359447	Anti-mesothelin Chimeric Antigen Receptors Anti-mesothelin Chimeric Antigen Receptors Anti-mesothelin Chimeric Antigen Receptors

6/10/2014	The United States Of America	Assignee	Application Publication	14352530 20140274909	Anti-cd22 Chimeric Antigen Receptors Anti-cd22 Chimeric Antigen Receptors

6/10/2014	The United States Of America	Assignee	Application Publication Application	14352530 20140274909 9868774	Anti-cd22 Chimeric Antigen Receptors Anti-cd22 Chimeric Antigen Receptors

4/14/2014	The United States Of America	Assignee	Application Publication Patent	14241782 20140213529 9206240	Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes

2/28/2014	The United States Of America	Assignee	Application Publication	14115131 20140154248	Recombinant Immunotoxin Targeting Mesothelin Recombinant Immunotoxin Targeting Mesothelin

2/28/2014	The United States Of America	Assignee	Application Publication Patent	14115131 20140154248 10683362	Recombinant Immunotoxin Targeting Mesothelin Recombinant Immunotoxin Targeting Mesothelin Recombinant Immunotoxin Targeting Mesothelin

1/21/2014	The United States Of America	Assignee	Application Publication Patent	14123971 20140094417 9346859	Pseudomonas Exotoxin A With Less Immunogenic T Cell And/or B Cell Epitop... Pseudomonas Exotoxin A With Less Immunogenic T Cell And/or B Cell Epitop... Pseudomonas Exotoxin A With Less Immunogenic T Cell And/or B Cell Epitop...

10/21/2013	The United States Of America	Assignee	Application Publication Patent	14428771 20150274836 9416190	Process for Production of Microalgae, Cyanobacteria and Metabolites Ther... Container Seal Container Seal

10/18/2013	The United States Of America	Assignee	Application Publication	14437889 20150299317	M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors

10/18/2013	The United States Of America	Assignee	Application Publication Patent	14437889 20150299317 10072078	M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors M971 Chimeric Antigen Receptors

10/16/2013	The United States Governement As Represe...	Assignee	Application	61844119	Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules

50 Rows Total

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

AI text generation	None
AI document summarization	None
AI-augmented search	None
AI-generated images	None
AI chat or Q&A interface	Linkable via MCP
Third party AI contribution in government documents	Possible